Scientists from Monash University are partnering with colleagues at the Yale School of Medicine in New Haven, Conn., to ...

A stroke is caused because of problems with blood flow in the brain and there are two kinds. Ischemic happens when there is a ...

Ultimately, investigators found a significant reduction in ischemic stroke risk with asundexian compared to placebo, both in combination with antiplatelet therapy. Additionally, participants had no ...

Among U.S. adults with obstructive sleep apnea, there has been an increase in deaths related to ischemic heart disease from 1999 to 2022, according to results published in Respiratory Medicine.“These ...

Topline data show the Factor XIa inhibitor asundexian lowers recurrent stroke risk vs placebo with no increase in major bleeding events.

Patients who have had a stroke are prescribed medication to prevent new strokes. Nevertheless, fewer than half achieve the ...

(HealthDay News) — Myelodysplastic syndrome (MDS) is independently associated with incident cardiovascular disease (CVD), according to a study published online Nov. 10 in the Canadian Journal of ...

Ischemic stroke, a leading cause of disability and mortality worldwide, is a complex cerebrovascular event with outcomes heavily influenced by the inflammatory response.

COVID-19 infection is associated with ischemic and hemorrhagic spinal stroke, with distinct clinical characteristics and underlying mechanisms.

Ischemic colitis reduces blood flow to the colon or large intestine. Mesenteric ischemia is a reduction in blood flow to the small intestine due to the narrowing of the arteries. Both conditions are ...

Canadian Patent No. 3043594, entitled “Method of Using Human Mesenchymal Stem Cells to Effect Cellular and Humoral Immunity,” provides Longeveron with patent rights in Canada through 2037.

There is a common misconception that ischemic limb necrosis results only from thrombosis or thromboembolism involving limb arteries, with loss of arterial pulses. Yet ischemic limb gangrene can also ...